Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Cell(2021)10.1016/j.cell.2021.09.020Source: DataRank Database

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 1,654 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1,654 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 93.23)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Beth A. Helmink ORCID,Padmanee Sharma ORCID,Jennifer A. Wargo ORCID,Golnaz Morad ORCID

Live enrichment

PubMed:34624224 PMC:PMC8767569 OpenAlex:https://openalex.org/W3203575974

Melanoma Research Alliance

Grant: 4022024

Parker Institute for Cancer Immunotherapy

Grant: 1R01CA219896-01A1

(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome

National Institutes of Health

Grant: 1F32CA260769-01

Elucidating the role of gut, blood, and tumor microbiota in brain metastasis

Stand up to Cancer

Grant: SU2C-AACR-IRG-19-17

NCI NIH HHS

Grant: R01 CA219896

NCI NIH HHS

Grant: F32 CA260769

Stand up to Cancer

Melanoma Research Alliance

NIH

FWCI

93.23

Citation Percentile

1.0%

Citation Trend

2013

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8767569

publisherhttps://api.elsevier.com/content/article/PII:S0092867421011016?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421011016?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.09.020

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerEpigenetics and DNA Methylation03 medical and health sciences0302 clinical medicineAnimalsDrug Resistance, NeoplasmHumansImmune Checkpoint InhibitorsImmune Checkpoint ProteinsImmunityImmunotherapyNeoplasms

MeSH Terms

Immune Checkpoint InhibitorsImmune Checkpoint ProteinsAnimalsHumansImmunityImmunotherapyNeoplasmsDrug Resistance, Neoplasm

Keywords

BiologyEpigenomeBlockadeImmune systemImmune checkpointImmunityImmunologyBioinformaticsImmunotherapyGeneticsGeneGene expressionDrug Resistance, NeoplasmNeoplasmsAnimalsHumansImmune Checkpoint ProteinsImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being